117 related articles for article (PubMed ID: 33021886)
1. The effect of temozolomide in combination with doxorubicin in glioblastoma cells
Horescu C; Elena Cioc C; Tuta C; Sevastre AS; Tache DE; Alexandru O; Artene SA; Danoiu S; Dricu A; Stefana Oana P
J Immunoassay Immunochem; 2020 Nov; 41(6):1033-1043. PubMed ID: 33021886
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide-Doxorubicin Conjugate as a Double Intercalating Agent and Delivery by Apoferritin for Glioblastoma Chemotherapy.
Du K; Xia Q; Heng H; Feng F
ACS Appl Mater Interfaces; 2020 Aug; 12(31):34599-34609. PubMed ID: 32648735
[TBL] [Abstract][Full Text] [Related]
3. Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres.
Kim HY; Lee BI; Jeon JH; Kim DK; Kang SG; Shim JK; Kim SY; Kang SW; Jang H
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31658771
[TBL] [Abstract][Full Text] [Related]
4. Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent.
Haas B; Ciftcioglu J; Jermar S; Weickhardt S; Eckstein N; Kaina B
J Cancer Res Clin Oncol; 2021 Mar; 147(3):779-792. PubMed ID: 33315125
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells.
Kaina B; Beltzig L; Piee-Staffa A; Haas B
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977591
[TBL] [Abstract][Full Text] [Related]
6. Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells.
Villodre ES; Kipper FC; Silva AO; Lenz G; Lopez PLDC
Mol Neurobiol; 2018 May; 55(5):4185-4194. PubMed ID: 28612256
[TBL] [Abstract][Full Text] [Related]
7. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
8. Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.
Lun X; Wells JC; Grinshtein N; King JC; Hao X; Dang NH; Wang X; Aman A; Uehling D; Datti A; Wrana JL; Easaw JC; Luchman A; Weiss S; Cairncross JG; Kaplan DR; Robbins SM; Senger DL
Clin Cancer Res; 2016 Aug; 22(15):3860-75. PubMed ID: 27006494
[TBL] [Abstract][Full Text] [Related]
9. Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells.
Silva VAO; Rosa MN; Miranda-Gonçalves V; Costa AM; Tansini A; Evangelista AF; Martinho O; Carloni AC; Jones C; Lima JP; Pianowski LF; Reis RM
Invest New Drugs; 2019 Apr; 37(2):223-237. PubMed ID: 29931585
[TBL] [Abstract][Full Text] [Related]
10. PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines.
Choi PJ; Cooper E; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Park TI; Jose J
Bioorg Med Chem Lett; 2020 Jul; 30(14):127252. PubMed ID: 32527552
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
[TBL] [Abstract][Full Text] [Related]
12. CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.
Kaur S; Ramdzan ZM; Guiot MC; Li L; Leduy L; Ramotar D; Sabri S; Abdulkarim B; Nepveu A
Neuro Oncol; 2018 Mar; 20(4):484-493. PubMed ID: 29036362
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
Skaga E; Skaga IØ; Grieg Z; Sandberg CJ; Langmoen IA; Vik-Mo EO
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1495-1507. PubMed ID: 31028540
[TBL] [Abstract][Full Text] [Related]
14. Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.
Karachi A; Yang C; Dastmalchi F; Sayour EJ; Huang J; Azari H; Long Y; Flores C; Mitchell DA; Rahman M
Neuro Oncol; 2019 Jun; 21(6):730-741. PubMed ID: 30668768
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.
Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S
Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977
[TBL] [Abstract][Full Text] [Related]
16. Probing the Oncolytic and Chemosensitizing Effects of Dihydrotanshinone in an
Kumar V; Radin D; Leonardi D
Anticancer Res; 2017 Nov; 37(11):6025-6030. PubMed ID: 29061781
[TBL] [Abstract][Full Text] [Related]
17. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
[TBL] [Abstract][Full Text] [Related]
18. Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells.
Zhang F; Liu R; Zhang H; Liu C; Liu C; Lu Y
BMC Cancer; 2020 Jul; 20(1):673. PubMed ID: 32682409
[TBL] [Abstract][Full Text] [Related]
19. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
He Y; Kaina B
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925722
[TBL] [Abstract][Full Text] [Related]
20. Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration.
Ahmadi-Zeidabadi M; Akbarnejad Z; Esmaeeli M; Masoumi-Ardakani Y; Mohammadipoor-Ghasemabad L; Eskandary H
Electromagn Biol Med; 2019; 38(3):198-209. PubMed ID: 31179753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
